The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease. Cliff ERS, Tessema FA. JAMA 2024;332:703-704.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cliff ERS, Tessema FA. The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease. JAMA 2024;332:703-704.
PMID: 39102257